Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited on...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Babić, Mirjana, Švob Štrac, Dubravka, Mück-Šeler, Dorotea, Pivac, Nela, Stanić, Gabrijela, Hof, Patrick R., Šimić, Goran
Natura: Artigo
Lingua:Inglês
Pubblicazione: Croatian Medical Schools 2014
Soggetti:
Cerebrospinal Fluid Physiology and Movement
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157375/
https://ncbi.nlm.nih.gov/pubmed/25165049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2014.55.347
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi